Drug intelligence / Profile preview

taraxasterol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Taraxasterol is a pentacyclic triterpene naturally occurring in plants such as *Taraxacum officinale* (dandelion). It has been identified as a potent anti-inflammatory and anti-cancer agent, particularly in the context of gastric diseases. Mechanistically, taraxasterol directly binds to and inhibits Protein Tyrosine Phosphatase 1B (PTP1B), a phosphatase often overexpressed in gastritis and gastric cancer tissues. This inhibition modulates the PTP1B/PKM2/NF-κB signaling axis, leading to a reduction in pro-inflammatory cytokines (e.g., TNF-α) and reactive oxygen species, while also suppressing the proliferation and colony formation of gastric cancer cells. In vivo studies have demonstrated its efficacy in reducing inflammation in *Helicobacter pylori*-induced gastritis models and inhibiting tumor growth in gastric cancer patient-derived xenograft (PDX) models.

Other names
AnthesterinTaraxasterin
02

Targets

TLR4 (Toll-like receptor 4)NR1H3 (Liver X receptor beta)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on taraxasterol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on taraxasterol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call